BioSyent Dividend
Dividend criteria checks 3/6
BioSyent is a dividend paying company with a current yield of 2.14% that is well covered by earnings.
Key information
2.1%
Dividend yield
30%
Payout ratio
| Industry average yield | 2.4% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Earnings per share | CA$0.56 |
| Dividend yield forecast in 3Y | n/a |
Recent dividend updates
Recent updates
BioSyent's (CVE:RX) Profits May Not Reveal Underlying Issues
Mar 22
BioSyent (CVE:RX) Will Pay A Larger Dividend Than Last Year At CA$0.045
Feb 09BioSyent Inc.'s (CVE:RX) Intrinsic Value Is Potentially 38% Above Its Share Price
Apr 14BioSyent Inc. (CVE:RX) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
Mar 19Declining Stock and Solid Fundamentals: Is The Market Wrong About BioSyent Inc. (CVE:RX)?
Mar 17BioSyent (CVE:RX) Shareholders Booked A 33% Gain In The Last Year
Feb 18
Here's Why BioSyent's (CVE:RX) Statutory Earnings Are Arguably Too Conservative
Jan 28BioSyent Inc. (CVE:RX) Shares Could Be 30% Below Their Intrinsic Value Estimate
Jan 07BioSyent Inc.'s (CVE:RX) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Dec 17Did BioSyent Inc. (CVE:RX) Insiders Buy Up More Shares?
Dec 02Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Too early to tell whether RX's dividend payments have been stable as they only just started paying a dividend.
Growing Dividend: Too early to tell if RX's dividend payments are increasing as they only just started paying a dividend.
Dividend Yield vs Market
| BioSyent Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (RX) | 2.1% |
| Market Bottom 25% (CA) | 1.9% |
| Market Top 25% (CA) | 6.5% |
| Industry Average (Pharmaceuticals) | 2.4% |
| Analyst forecast in 3 Years (RX) | n/a |
Notable Dividend: RX's dividend (2.14%) is higher than the bottom 25% of dividend payers in the Canadian market (1.92%).
High Dividend: RX's dividend (2.14%) is low compared to the top 25% of dividend payers in the Canadian market (6.49%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (29.6%), RX's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (42.8%), RX's dividend payments are well covered by cash flows.